BCC Research Strattera ® Forecast

Published - Jul 2014| Analyst - Jackson Highsmith| Code - FMO002A
Market Research Report Single User License: $3500

Report Highlights

BCC Research is pleased to announce the BCC Research Strattera ® Forecast , a strategic investment product designed to provide market data for the pharmaceutical drug Strattera ®, a treatment for Attention Deficit Hyperactivity Disorder (ADHD) distributed by Eli Lilly and Company. Strattera ® will lose its branded patent protection in late 2016 going into 2017, opening the market to distribution of generic treatments by competing companies.

With BCC Research's Strattera ® Forecast, you will have quantitative data about forecasted revenue for the pharmaceutical drug Strattera ®  that will guide you in your strategic decision-making regarding future participation in this product sector.

The BCC Research Strattera ® Forecast is a quantitative forecast model in an easily accessible Microsoft® Excel® spreadsheet,  featuring:

  • Market demand forecasts for Strattera ® annually for the years 2016 to 2030 by volume (number of patients) and value (in U.S. dollars)
  • Segmentation of volume and value for these regions:
    • United States
    • Japan
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
  • Interactive data for:
    • Patient volumes, with forecasts by age range and prevalence, as well as population estimates
    • Product pricing forecasts

Use the BCC Research Strattera ® Forecast to:

  • Examine forecasted market demand for Strattera ®
  • Validate other Strattera ® market-demand data to which you have access
  • Make strategic decisions about entering Strattera ®-related or Attention Deficit Hyperactivity Disorder (ADHD) treatment-related markets

Strattera ® is a registered trademark of Eli Lilly and Company. Microsoft and Excel are registered trademarks of Microsoft Corporation.

Figure 1- Summary graphs-Value in USD and Patient Volumes, by Region, 2010-2030

Table 1-Total market graphs-Revenue by Region and Patient Volumes, 2016 to 2030

Table 2-US Patient Volumes, 2010 to 2030

Table 3-Japan Patient Volumes, 2010 to 2030

Table 4-France Patient Volumes, 2010 to 2030

Table 5-German Patient Volumes, 2010 to 2030

Table 6-Italy Patient Volumes, 2010 to 2030

Table 7-Spain Patient Volumes, 2010 to 2030

Table 8-UK Patient Volumes, 2010 to 2030

Table 9-US Population Estimates, Sex and Age, 2015 to 2060

Table 10-Europe Population Estimates, 2010 to 2030

Table 11-Japan Population Estimates, 2010 to 2030

Table 12-US Pricing and FX Rates, Strattera Annual Costs, 2010 to 2030

Table 13-Japan Pricing and FX Rates, Strattera Annual Costs, 2010 to 2030

Table 14-France Pricing and FX Rates, Strattera Annual Costs, 2010 to 2030

Table 15-German Pricing and FX Rates, Strattera Annual Costs, 2010 to 2030

Table 16-Spain Pricing and FX Rates, Strattera Annual Costs, 2010 to 2030

Table 17-UK Pricing and FX Rates, Strattera Annual Costs, 2010 to 2030

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at(+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price
Full Report: BCC Research Strattera ® Forecast $3500
Chapter- 1: Introduction Free Download
Download Table of Contents
RELATED REPORTS
Share This Report